Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 6, No 4 (2014) Current guidelines and prospects for using novel oral anticoagulants for nonvalvular atrial fibrillation Abstract  similar documents
A. V. Fonyakin
"... into account when choosing oral anticoagulant therapy after hemorrhagic stroke in patients at high risk ..."
 
Vol 8, No 4 (2016) GLOBAL CLINICAL PRACTICE AND PERSONALIZED CHOICES FOR ORAL ANTICOAGULANT THERAPY FOR NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
A. V. Fonyakin, L. A. Geraskina
"... oral anticoagulants (DOACs). The start of clinical use of these agents has opened a new page in oral ..."
 
Vol 7, No 2 (2015) The fifth anniversary of clinical use of new oral anticoagulants in non-valvular atrial fibrillation Abstract  similar documents
A. V. Fonyakin
"... a new page in oral anticoagulant therapy aimed at preventing thromboembolic events in AF. Dabigatran ..."
 
Vol 8, No 1 (2016) Hemorrhagic stroke and oral anticoagulants: What is to be done? Abstract  similar documents
M. A. Domashenko
"... in the incidence of intracranial hemorrhage (ICH) associated with the use of oral anticoagulants. The paper ..."
 
Vol 5, No 3 (2013) Prevention of venous thromboembolic events in ischemic stroke Abstract  similar documents
Vladimir Anatolyevich Parfenov
"... The prevention of venous thromboembolic events (VTEEs) combining leg vein thrombosis and pulmonary ..."
 
Vol 4, No 3 (2012) A new era of anticoagulant therapy in the prevention of stroke in non-rheumatic atrial fibrillation Abstract  similar documents
Andrei Viktorovich Fonyakin, L A Geraskina
"... arrhythmia and a common cause of cardiogenic cerebral embolism. Oral anticoagulant therapy is a leader ..."
 
Vol 7, No 1 (2015) Cardioembolic stroke Abstract  similar documents
I. V. Damulin, D. A. Andreev, Z. K. Salpagarova
"... to ischemic stroke. Oral anticoagulants, the efficacy and safety of which have been proven in large clinical ..."
 
Vol 6, No 2S (2014): Special issue "Stroke" Secondary prevention of stroke in atrial fibrillation, use of apixaban: ARISTOTLE, AVERROES studies Abstract  similar documents
V.A. Parfenov, S.V. Verbitskaya
"... and new oral anticoagulants: inhibitors of Xa factor (apixaban, rivaroxaban) and direct thrombin inhibiror ..."
 
Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания Atherothrombotic stroke in non-valvular atrial fibrillation Abstract  similar documents
I. S. Yavelov, E. Yu. Okshina
"... in preventing non-cardioembolic (atherothrombotic in particular) strokes, and the widespread use of oral ..."
 
Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания Intracranial hemorrhage in patients taking oral anticoagulants. Current possibilities for therapy Abstract  similar documents
S. N. Yanishevsky
"... oral anticoagulants. The incidence of ICH is shown to be considerably lower when nonvitamin K-dependent ..."
 
Vol 5, No 4 (2013) Cardioembolic stroke: a variety of causes and current approaches to its prevention Abstract  similar documents
Lyudmila Aleksandrovna Geraskina
"... антагонисты витамина К – АВК (аценокумарол, фениндион) были дос- тупны для перорального применения благодаря ..."
 
Vol 6, No 2 (2014) Dabigatran etexilate for nonvalvular atrial fibrillation in real practice and promises for its use to prevent stroke Abstract  similar documents
A.V. Fonyakin
"... fibrillation (AF) are substantially extended after designing and clinically introducing new oral anticoagulants ..."
 
Vol 7, No 4 (2015) Topical issues of the efficiency and safety of using the first direct thrombin inhibitor in real clinical practice Abstract  similar documents
A. V. Fonyakin
"... . It was particularly emphasized that direct oral anticoagulants along with warfarin as fist-line agents might be used ..."
 
Vol 10, No 2 (2018) Molecular mechanisms of action of glucosamine sulfate in the treatment of degenerative-dystrophic diseases of the joints and spine: results of proteomic analysis Abstract  similar documents
O. A. Gromova, I. Yu. Torshin, A. M. Lila, A. N. Gromov
 
Vol 10, No 3 (2018) Current strategies to improve the efficiency and safety of prevention and treatment of embolic stroke in non-valvular atrial fibrillation: possibilities of neutralizing therapy Abstract  similar documents
S. N. Yanishevsky
"... with ischemic stroke (IS) who take oral anticoagulants. The possibilities of providing effective and relatively ..."
 
Vol 5, No 4 (2013) Venous thromboses and thromboembolism in acute stroke: risk factors, diagnosis, treatment, and prevention Abstract  similar documents
Andrei Viktorovich Fonyakin, L A Geraskina
"... the risk of hemorrhagic complications. Novel oral anticoagulants used to treat venous thrombosis and VTE ..."
 
Vol 9, No 2 (2017) Antiplatelet therapy strategies for ischemic stroke Abstract  similar documents
M. Yu. Maksimova, A. V. Fonyakin, L. A. Geraskina
"... . Parenteral anticoagulants in acute stroke decrease the risk of venous thrombosis/thromboembolism, oral ..."
 
Vol 8, No 4 (2016) IMPACT OF ANTICOAGULANT THERAPY ON THE INDICATORS OF ARTERIAL STIFFNESS AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ATRIAL FIBRILLATION AFTER CARDIOEMBOLIC STROKE Abstract  similar documents
I. A. Zolotovskaya, I. L. Davydkin, I. E. Poverennova, N. P. Romanchuk
"... Objective: to investigate the impact of anticoagulant therapy on the indicators of arterial ..."
 
Vol 6, No 1 (2014) Rivaroxaban in secondary prevention of cardioembolic stroke: standards and abnormal situations Abstract  similar documents
A.V. Fonyakin, L.A. Geraskina
"... with nonvalvular atrial fibrillation (AF) were significantly broadened after new oral anticoagulants (NOC) have ..."
 
Vol 5, No 2S (2013): Special issue "Stroke" Current approaches to antithrombotic therapy in patients with cardioembolic stroke Abstract  similar documents
Oleg Ivanovich Vinogradov, A N Kuznetsov, N V Rybalko
"... of trials of new oral anticoagulants, and latest guidelines for antithrombotic therapy to prevent stroke ..."
 
Vol 6, No 3 (2014) The risk factors and prevention of stroke in atrial fibrillation Abstract  similar documents
V. A. Parfenov, S. V. Verbitskaya
"... randomized trials that show that novel oral anticoagulants (dabigatran, rivaroxaban, apixaban) are as good ..."
 
Vol 1, No 3-4 (2009) ANTITHROMBOCYTIC THERAPY IN THE SECONDARY PREVENTION OF ISCHEMIC STROKE Abstract  similar documents
Andrey Viktorovich Fonyakin, L A Geraskina, Andrey Viktorovich Fonyakin, L A Geraskina
"... not limit the choice of an antithrombocytic agent to only oral (indirect) anticoagulants (OAC). If OAC ..."
 
Vol 1, No 2 (2009) ANTITHROMBOTIC THERAPY IN THE PREVENTION OF RECURRENT ISCHEMIC STROKE Abstract  similar documents
Andrey Vladimirovich Fonyakin, Andrey Vladimirovich Fonyakin
"... therapy with oral anticoagulants is reasonable in cardioembolic stroke caused by atrial fibrillation ..."
 
Vol 8, No 4 (2016) USE OF DIMETHYL FUMARATE IN THE TREATMENT OF MULTIPLE SCLEROSIS: CLINICAL AND ECONOMIC ANALYSIS Abstract  similar documents
V. R. Mkrtchyan, L. V. Brylev, I. A. Shpak, A. M. Sergeev
"... evaluation was made to study the use of first-line oral dimethyl fumarate versus another first-line oral ..."
 
Vol 5, No 2 (2013) Dabigatran experience in primary and secondary prevention of cardioembolic stroke Abstract  similar documents
Maksim Alekseyevich Domashenko, M Yu Maksimova, D Z Korobkova, M E Gafarova
"... The review of novel oral anticoagulants (dabigatran, rivaroxaban and apixaban) in stroke prevention ..."
 
Vol 4, No 1S (2012): Special issue "Epilepsy" Efficacy and tolerance of intravenous lacosamide in urgent neurological situations Abstract  similar documents
P. N. Vlasov, E. G. Kamelkova, F. R. Drozzhina
"... is promising when its oral use is impossible, including in therapy for status epilepticus/series of partial ..."
 
Vol 4, No 4 (2012) Subtypes of ischemic cerebral circulation disorders at young age: diagnosis and treatment Abstract  similar documents
Natalia Vyacheslavovna Pizova
"... tissue plasminogen activator is more frequently used; oral anticoagulants and antiplatelet agents ..."
 
Vol 3, No 4 (2011) Pharmacoeconomic analysis of the use of movalis (meloxicam) in patients with nonspecific back pain Abstract  similar documents
O N Gerasimova, Vladimir Anatolyevich Parfenov
"... in the outpatient setting. Movalis was given in a single daily oral dose of 15 mg throughout the follow-up; the oral ..."
 
Vol 11, No 2 (2019) Possible timing for anticoagulation therapy initiation in ischemic stroke patients with atrial fibrillation: further analysis of the hemorrhagic transformation index Abstract  PDF (Eng)  similar documents
M. N. Kalinin, D. R. Khasanova, M. M. Ibatullin
"... an appropriate scale (the hemorrhagic transformation index (HTI)) to clarify the possible timing of anticoagulant ..."
 
Vol 1, No 1 (2009) THE ACUTE PERIOD OF ISCHEMIC STROKE: DIAGNOSIS AND TREATMENT Abstract  similar documents
V A Parfenov, V A Parfenov
"... ,5 hours after its development. The value of anticoagulants, antithrombocytic, neuroprotective, and other ..."
 
Vol 3, No 3 (2011) Prevention of Alzheimer's disease Abstract  similar documents
V A Parfenov
"... as oral medications. The paper also presents the results of a placebo-controlled trial that has indicated ..."
 
Vol 1, No 3-4 (2009) CITICOLIN IN THE TREATMENT OF STROKE AND VASCULAR COGNITIVE DISORDERS Abstract  similar documents
Vladimir Anatol'evich Parfenov, Vladimir Anatolyevich Parfenov
"... evidence for the efficacy of intravenous or oral citicolin used within the first 24 hours of ischemic ..."
 
Vol 7, No 4 (2015) Dysphagia after stroke Abstract  similar documents
D. O. Gromova, V. V. Zakharov
"... for these patients. The authors show the advantages of fast-dissolving oral medicines used in the therapy of patients ..."
 
Vol 10, No 1 (2018) Cranial dystonia Abstract  similar documents
V. A. Tolmacheva
"... cranial dystonia. If their administration cannot achieve a positive result, oral drugs and surgical ..."
 
Vol 3, No 1 (2011) Current aspects of the epidemiology and treatment of chronic brain ischemiain the presence of essential hypertension (results of the CALIPSO program) Abstract  similar documents
Elena Igorevna Chukanova, Elena Igorevna Chukanova
"... and 50 mg on days 5 to 7) then oral Cavinton forte, 30 mg/day, for 90 days. Therapy with Cavinton ..."
 
Vol 4, No 2 (2012) Secondary prevention of ischemic stroke: from recommendations to real clinical practice Abstract  similar documents
V A Shandalin, A V Fonyakin, L A Geraskina
"... with antithrombotic agents, indirect anticoagulants in particular (p < 0.05). ..."
 
Vol 7, No 4 (2015) Some aspects of treatment for cognitive impairments. Cyticolin: pharmacological characteristics, possible benefits, aspects of use Abstract  similar documents
N. V. Trofimova, I. S. Preobrazhenskaya
"... pathways of acetylcholine biosynthesis. The VITA and IDEALE have shown that the parenteral and oral ..."
 
Vol 7, No 4 (2015) Possibilities of using naftidrofuryl in the therapy of cerebrovascular diseases: Literature review and the authors’ observations Abstract  similar documents
A. N. Belova, D. N. Shakurova, E. V. Gayazova
"... in this category of patients. The data available in the literature suggest that oral naftidrofuryl has a good ..."
 
Vol 1, No 3-4 (2009) ACETYLCALICYLIC ACID AND PREVENTION OF STROKE IN HIGH-RISK GROUP PATIENTS Abstract  similar documents
Igor' Semenovich Yavelov, Igor Semenovich Yavelov
"... anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular ..."
 
Vol 4, No 1 (2012) Current approaches to therapy for chronic forms of cerebrovascular diseases Abstract  similar documents
Maksim Alekseyevich Domashenko, M Yu Maksimova, T A Popova, M M Tanashyan
"... with atherosclerosis of the great arteries of the brain, essential hypertension), indirect anticoagulants (in patients ..."
 
Vol 4, No 1 (2012) New possibilities in the prevention of stroke in atrial fibrillation Abstract  similar documents
Vladimir Anatolyevich Parfenov, S V Verbitskaya
"... into neurological care may increase the number of patients receiving effective anticoagulant therapy to prevent re ..."
 
Vol 4, No 4 (2012) Citicoline for ischemic stroke: ICTUS trial Abstract  similar documents
Vladimir Anatolyevich Parfenov
"... , затем перорально по I таблетке 500 мг каждые I2 ч) на протяжении 6 нед. Результаты исследования ..."
 
Vol 10, No 3 (2018) Correlation of the aesthetic component of dental health and emotional state in patients with different anxiety levels Abstract  similar documents
O. I. Lobach, V. N. Nikolenko, E. K. Rustamova, N. V. Lapina, E. V. Kochurova, L. A. Skorikova, L. V. Gavrushova
"... Organization Quality of Life (WHOQOL-BREF-26) questionnaire; the updated Oral Health Impact Profile (OHIP-14 ..."
 
Vol 6, No 2S (2014): Special issue "Stroke" Cryptogenic stroke Abstract  similar documents
N.A. Shamalov, M.A. Kustova
"... они содержат тромбы, яв- ляющиеся патологической основой тромбоэмболического инсульта. Чаще всего ..."
 
Vol 8, No 3 (2016) Chemoreactome analysis of ethylmethylhydroxypyridine succinate Abstract  similar documents
O. A. Gromova, I. Yu. Torshin, L. E. Fedotova, A. N. Gromov
"... , and anticoagulant actions, activates homocysteine neutralization and anti-inflammatory protection, and decreases ..."
 
Vol 2, No 4 (2010) Management of patients with back pain in outpatient practice Abstract  similar documents
O N Gerasimova, Vladimir Anatol'evich Parfenov, O N Gerasimova, Vladimir Anatolyevich Parfenov
"... , напроксен и пироксикам), и более низким чис- лом тромбоэмболических осложнений, чем при терапии ди ..."
 
Vol 1, No 3-4 (2009) TREATMENT FOR ACUTE NONSPECIFIC BACK PAIN IN OUTPATIENT PRACTICE Abstract  similar documents
O N Gerasimova, Vladimir Anatol'evich Parfenov, O N Gerasimova, Vladimir Anatolyevich Parfenov
"... (диклофенак, напроксен и пироксикам), и меньшее количество тромбоэмболических осложнений по сравнению с ..."
 
Vol 1, No 1 (2009) ANTITHROMBIC THERAPY IN THE PRIMARY PREVENTION OF STROKE Abstract  similar documents
I S Yavelov, I S Yalevov
"... . Oral Anticoagulant Therapy in Patients With Coronary artery Disease: A Meta-Analysis. JAMA 1999 ..."
 
Vol 7, No 3 (2015) Pharmacoeconomic analysis of the use of first- and second-line drugs in the treatment of multiple sclerosis Abstract  similar documents
V. R. Mkrtchyan, L. V. Brylev, O. V. Davydova, A. V. Belyanin, I. A. Shpak, A. M. Sergeev
"... ), subcutaneous glatiramer acetate (copaxone, 20 mg), intravenous natalizumab (tyzabri, 300 mg), and oral ..."
 
Vol 4, No 4 (2012) Current approaches to preventing and treating chronic cerebral circulatory disorder Abstract  similar documents
Marina Yuryevna Maksimova, M A Domashenko, M M Tanashyan
"... hypertension), indirect anticoagulants (for atrial fibrillation), statins. It details the results of clinical ..."
 
1 - 50 of 174 Items 1 2 3 4 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)